Peripheral Vascular Devices Market to Grow from USD 10.02 Billion in 2026 to USD 13.22 Billion by 2031, at a CAGR of 5.7% – MarketsandMarkets™

Delray Beach, FL, Aug. 27, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global peripheral vascular devices market will grow from USD 10.02 billion in 2026 to USD 13.22 billion by 2031, at a CAGR of 5.7% during the forecast period. Market growth is driven by the rising incidence of peripheral artery disease (PAD) and similar vascular conditions, supported by the growing elderly population and increasing rates of diabetes, obesity, and smoking. More efficient payment systems for endovascular surgeries and the growing preference for less-invasive treatments offering shorter hospital stays and faster recovery are further accelerating adoption. Advancements in stents, balloons, atherectomy techniques, and imaging systems are improving clinical outcomes and expanding treatment options, while increasing awareness and the development of advanced healthcare systems in emerging markets are supporting the overall growth of the market.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

Key Market Highlights

• Market size, 2026: USD 10.02 billion
• Market forecast, 2031: USD 13.22 billion
• Growth rate: CAGR of 5.7% (2026–2031)
• Largest angioplasty stents segment: Drug-eluting stents
• Largest endovascular aneurysm repair stent graft segment: Abdominal aortic aneurysm stent grafts
• Largest inferior vena cava filters segment: Retrievable filters
• Largest catheter segment: Angiography catheters
• Largest angioplasty balloons segment: Old/normal balloons
• Largest plaque modification devices segment: Atherectomy devices
• Largest hemodynamic flow alteration devices segment: Embolic protection devices
• Prominent other peripheral vascular devices segment: Guidewires
• Largest end-user segment: Hospitals
• Key growth region: Asia Pacific
• Key players: Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company, Abbott, Terumo Corporation, B. Braun Melsungen AG, Merit Medical Systems, Penumbra, Inc., Koninklijke Philips N.V., Stryker, Cordis, W. L. Gore & Associates, Endologix LLC, Cook Medical, Edwards Lifesciences Corporation, iVascular S.L.U., Biosensors International Group, Ltd., InSitu Technologies, Inc., and Meril Life Sciences.

Why This Market Matters

The rising incidence of peripheral artery disease, diabetes, and other vascular disorders is creating sustained demand for peripheral vascular devices. An aging global population, increasing obesity, smoking, and lifestyle-related risk factors are contributing to the growing prevalence of vascular disease and increasing the need for angioplasty, stenting, atherectomy, thrombectomy, and other endovascular interventions.

The growing preference for minimally invasive endovascular procedures is another important factor supporting market expansion. These procedures can reduce hospital stays and recovery times compared with more invasive treatment approaches. Technological advances in drug-coated balloons, advanced stents, atherectomy systems, and image-guided navigation are improving patient care and expanding the number of patients eligible for treatment.

Market Overview

The peripheral vascular devices market encompasses a broad range of technologies used for the diagnosis and treatment of peripheral vascular disorders. These include angioplasty stents, endovascular aneurysm repair stent grafts, inferior vena cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, and other peripheral vascular devices.

The market is benefiting from continued investments in healthcare infrastructure, an increasing number of catheterization laboratories and ambulatory surgical centers, and growing awareness and early diagnosis of vascular diseases. Product innovations focused on improved deliverability, safety, and long-term effectiveness are supporting adoption across developed and emerging healthcare markets.

Analyst Perspective

The growing geriatric population represents a major driver for the peripheral vascular devices market. Older adults are particularly susceptible to peripheral artery disease, atherosclerosis, and diabetes, increasing demand for procedures such as angioplasty, stenting, atherectomy, and thrombectomy. There is also increasing demand for less-invasive and low-risk devices that can facilitate faster recovery among elderly patients.

Emerging economies offer significant growth opportunities due to increasing obesity, urbanization, sedentary lifestyles, and unhealthy eating habits. These factors are contributing to higher rates of diabetes, hypertension, and peripheral artery disease, while improvements in medical infrastructure are making interventional care more accessible. Rising healthcare spending and growing physician awareness are also increasing procedure volumes and demand for cost-effective, less-invasive peripheral vascular devices.

However, alternative treatment options remain a restraint for the market. Advances in pharmacological therapies, including antiplatelet agents, anticoagulants, lipid-lowering medications, and diabetes management strategies, can effectively control disease and symptoms in certain patient groups. Supervised exercise therapy, lifestyle modification, and non-invasive vascular care pathways can also delay or eliminate the need for endovascular procedures in some cases.

Product failures and device recalls represent another major challenge. Stent fractures, balloon failures, coating delamination, and thrombotic complications can result in adverse outcomes, recalls, post-market investigations, and increased regulatory scrutiny. These events can affect clinician confidence, delay product launches, and create legal and reputational risks for manufacturers.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=790

Segment Analysis

By angioplasty stents, drug-eluting stents dominated the market in 2025. These devices demonstrate better clinical outcomes than bare-metal stents by reducing neointimal hyperplasia and improving long-term vessel patency. Continued research into polymer coatings and drug-delivery systems, along with increasing use of endovascular therapies for complex peripheral lesions, is supporting demand for drug-eluting stents.

By endovascular aneurysm repair stent grafts, abdominal aortic aneurysm stent grafts dominated the market in 2025. Growth is supported by increasing aneurysm prevalence, particularly among elderly patients and individuals with high blood pressure, a history of smoking, or heart disease. The clinical preference for EVAR over open surgery, combined with the development of low-profile, modular, and advanced stent graft designs, is supporting this segment.

By inferior vena cava filters, retrievable filters dominated the market in 2025. Their adoption is supported by the increasing incidence of venous thromboembolism and the growing population of patients who cannot undergo long-term anticoagulant therapy. New filter designs offering easier retrieval, fewer long-term complications, and improved procedural safety are further supporting demand.

By catheters, angiography catheters led the market in 2025. Their adoption is driven by the increasing prevalence of peripheral artery disease and other vascular disorders requiring precise imaging for intervention. Improvements in catheter design, including enhanced trackability, torque response, and radiopacity, are also contributing to clinical adoption.

By angioplasty balloons, old/normal balloons dominated the market in 2025. Their lower cost, ease of use, and high clinical acceptance for lesion preparation and pre- and post-dilatation continue to support their leading position. Their compatibility with guidewires and stent systems and demand from emerging economies further contribute to segment growth.

By plaque modification devices, atherectomy devices dominated the market in 2025. Their growth is supported by the increasing incidence of PAD and the presence of complex, calcified lesions that can be difficult to treat with conventional angioplasty or stenting. Directional, rotational, orbital, and laser atherectomy technologies are expanding treatment options and supporting vessel-preserving strategies.

By hemodynamic flow alteration devices, embolic protection devices dominated the market in 2025. Their growing use is associated with the increasing adoption of endovascular treatments and the need to reduce the risk of distal embolization during complex peripheral interventions. Technological improvements in deliverability, capture efficiency, and vessel compatibility are further supporting adoption.

Among other peripheral vascular devices, guidewires held a prominent position in 2025. Guidewires are essential throughout minimally invasive endovascular procedures, supporting lesion crossing, device delivery, and procedural precision. Improvements in torque control, coatings, trackability, and specialized designs for complex and calcified lesions are supporting market growth.

By end user, hospitals led the peripheral vascular devices market in 2025. Hospitals manage a high volume of complex peripheral vascular cases and have the infrastructure, multidisciplinary expertise, and post-surgical capabilities required for advanced procedures. Increasing adoption of hybrid operating rooms, advanced imaging systems, and specialized vascular teams is further supporting hospital demand.

Regional Analysis

Asia Pacific is the primary driver of growth in the global peripheral vascular devices market. The region is benefiting from a rapid increase in peripheral artery disease, diabetes, and obesity, along with a large patient population, aging demographics, and rapid urbanization. Smoking, high blood pressure, and physical inactivity are contributing to the rising burden of vascular disorders in China, India, Japan, South Korea, and Southeast Asian countries.

The expansion of modern catheterization laboratories, hybrid operating rooms, and dedicated vascular centers is facilitating more peripheral interventions across the region. Rising healthcare expenditures, broader public and private insurance coverage, and government initiatives aimed at improving vascular and endovascular care are further supporting market growth. Increasing physician awareness, earlier diagnosis, and the growing presence of global manufacturers through local production, joint ventures, and distribution partnerships are strengthening the region's position as one of the fastest-growing markets.

Key Industry Trends

• Rising prevalence of peripheral artery disease
• Increasing geriatric population
• Growing incidence of diabetes and obesity
• Increasing smoking-related vascular disease
• Growing preference for minimally invasive endovascular procedures
• Increasing adoption of drug-eluting stents
• Growing use of drug-coated balloons
• Advancements in atherectomy systems
• Increasing adoption of advanced imaging and image-guided navigation
• Growing use of embolic protection devices
• Increasing adoption of EVAR
• Development of low-profile and modular stent grafts
• Increasing use of specialized guidewires for complex lesions
• Expansion of catheterization laboratories and ambulatory surgical centers
• Growing adoption of peripheral interventions in emerging economies.

Competitive Landscape

The global peripheral vascular devices market exhibits moderate to high market concentration, with major multinational companies dominating through strong clinical portfolios and extensive access to hospitals and physicians. Key players include Medtronic, Boston Scientific, Abbott, Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, Merit Medical Systems, Penumbra, Koninklijke Philips, Stryker, Cordis, W. L. Gore & Associates, Endologix, and Cook Medical.

Leading companies are competing through product innovation, clinical evidence generation, strategic acquisitions, partnerships, and international distribution networks. Their portfolios span drug-coated balloons, peripheral stents, atherectomy systems, thrombectomy devices, embolic protection systems, endovascular aneurysm repair products, and vascular access and imaging technologies.

Related Reports
North America Peripheral Vascular Devices Market
Europe Peripheral Vascular Devices Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/